Prospects for Personalized Therapy of Severe Bronchial Asthma
The emergence of biological medicine in the treatment of bronchial asthma has opened new prospects for a personalized approach to the treatment of severe forms of the disease. Practical experience in the use of targeted medicines in different regions of the world is extremely heterogeneous, and the choice in each specific clinical situation, given their narrowly focused effect, requires clear guidelines. The article uses the materials of the conciliation report of the joint group of experts of the Association of Russian-speaking specialists in the field of respiratory medicine "Severe bronchial asthma" and sets out the basic principles of evaluation of phenotypes of severe asthma and individualized choice of immunobiological therapy.